Are viruses associated with human breast cancer? Scrutinizing the molecular evidence Deepti JoshiGertrude Case Buehring Review 25 January 2012 Pages: 1 - 15
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer? Lian-Ming WuJia-Ni HuJian-Rong Xu Review 04 April 2012 Pages: 17 - 28
Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma Mark N. JabbourCleo Y. MassadFouad I. Boulos Review 08 April 2012 Pages: 29 - 37
Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers Rita NahtaRuth M. O’Regan Review 20 April 2012 Pages: 39 - 48
Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification Robert KornegoorCathy B. MoelansPaul J. van Diest Preclinical Study Open access 13 April 2012 Pages: 49 - 58
Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression Judy PangKathy A. ToyCelina G. Kleer Preclinical Study 13 April 2012 Pages: 59 - 66
NFκB signaling is important for growth of antiestrogen resistant breast cancer cells Christina W. YdeKristina B. EmdalAnne E. Lykkesfeldt Preclinical Study 18 April 2012 Pages: 67 - 78
Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor Elizabeth IornsToby M. WardMarc Lippman Preclinical study 26 April 2012 Pages: 79 - 91
Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation Yong Hannah WenAlice HoEdi Brogi Preclinical Study 27 April 2012 Pages: 93 - 102
Auto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival Sumit JainJianqin WeiNanette H. Bishopric Preclinical Study 05 May 2012 Pages: 103 - 114
Nuclear nano-morphology markers of histologically normal cells detect the “field effect” of breast cancer Rajan K. BistaPin WangYang Liu Preclinical Study 16 June 2012 Pages: 115 - 124
Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer Sylvie M. NoordermeerMarloes WennemersBert A. van der Reijden Preclinical study Open access 16 June 2012 Pages: 125 - 133
BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients Jasmina Z. CerneLin ZongSean E. McGuire Preclinical study 16 June 2012 Pages: 135 - 143
Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology Marek AncukiewiczCynthia L. MillerAlphonse G. Taghian Preclinical study 19 June 2012 Pages: 145 - 152
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression Ana Cristina VargasAmy E. McCart ReedSunil R. Lakhani Preclinical Study 21 June 2012 Pages: 153 - 165
A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivity Alexandra A. BeckerMonika K. GraeserRita K. Schmutzler Preclinical Study 23 June 2012 Pages: 167 - 175
High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers G. L. ChewD. HuangE. W. Thompson Preclinical Study 23 June 2012 Pages: 177 - 187
111In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer Aisha FasihHumphrey FongeRaymond M. Reilly Preclinical Study 27 June 2012 Pages: 189 - 200
Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors Yong Soon ChunTakahiro YoshidaSaraswati Sukumar Preclinical Study 01 July 2012 Pages: 201 - 208
Intraoperative ultrasound guidance for excision of non-palpable invasive breast cancer: a hospital-based series and an overview of the literature M. W. BarentszT. van DalenH. M. Verkooijen Clinical Trial 25 July 2012 Pages: 209 - 219
Predicting two-year quality of life after breast cancer surgery using artificial neural network and linear regression models Hon-Yi ShiJinn-Tsong TsaiMing-Feng Hou Clinical Trial 27 July 2012 Pages: 221 - 229
Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy Bas B. KoolenRenato A. Valdés OlmosEmiel J. Th. Rutgers Clinical Trial 28 July 2012 Pages: 231 - 240
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer Richard H. De BoerDusan KotasekPeter A. Kaufman Clinical Trial Open access 29 July 2012 Pages: 241 - 252
Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A Elena SperkGrit WelzelFrederik Wenz Clinical Trial 29 July 2012 Pages: 253 - 260
Statin use and risk of breast cancer: a meta-analysis of observational studies Krishna UndelaVallakatla SrikanthDipika Bansal Epidemiology 18 July 2012 Pages: 261 - 269
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences Annemiek B. G. KwastKarin C. G. M. Groothuis-OudshoornSabine Siesling Epidemiology 19 July 2012 Pages: 271 - 280
Impact of comorbidity on management and mortality in women diagnosed with breast cancer Anders BerglundAnnette WigertzMats Lambe Epidemiology 26 July 2012 Pages: 281 - 289
Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program Solveig HofvindChristoph I. LeeJoann G. Elmore Epidemiology 26 July 2012 Pages: 291 - 299
PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer A. PratJ. S. ParkerC. M. Perou Brief Report Open access 03 July 2012 Pages: 301 - 306
Feature extraction via composite scoring and voting in breast cancer Martin KochMarkus HanlMichael Wiese Brief Report 26 July 2012 Pages: 307 - 318
MRI in residual tumor size measurement in patient with breast cancer receiving neoadjuvant chemotherapy calls for caution Lian-Ming WuJiani HuJian-Rong Xu Letter to the Editor 01 August 2012 Pages: 319 - 320
Breast fat and breast cancer Andreas PetterssonRulla M. Tamimi Letter To the Editor 02 August 2012 Pages: 321 - 323